🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study was designed to evaluate the efficacy, safety, and pharmacokineti...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2023-04-06
Trial ID
NCT05701709
Treatments Being Tested
Evaluate the safety, tolerability, and objective response rate (ORR) of SHR...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-10-09
Trial ID
NCT07175220
Treatments Being Tested
This is a first in human, open-label, single-arm, multicenter dose escalati...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2023-03-03
Trial ID
NCT05735275
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Shanxi Cancer hospital
Start Date
2025-03-28
Trial ID
NCT06895928
This is a Phase II, open-label, seven-arm parallel study evaluating the eff...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2022-06-30
Trial ID
NCT05076682
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Chinese People's Liberation Army General Hospital
Start Date
2024-07-30
Trial ID
NCT06512051
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University
Start Date
2024-06-20
Trial ID
NCT06474468
Treatments Being Tested
This study is a multicentre, open phase II clinical study of dose escalatio...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2025-04-28
Trial ID
NCT06915142
Treatments Being Tested
In phase II, the main objective is to evaluate the efficacy of SHR-A2102 co...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-25
Trial ID
NCT06879145
Treatments Being Tested